CL Mobile Menu

Diatech files IND for infection agent

Diatech files IND for infection agent

Peptide-based imaging agent developer Diatech of Londonderry, NH, has filed an investigational new drug (IND) application with the Food and Drug Administration for a new radiopharmaceutical that detects infections of unknown origin. The agent, Tc-99m P483H, is a technetium-99m-labeled synthetic peptide designed to home in on infection sites where white blood cells are elevated as the body fights infection.


Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.